Plenary: Evolving HIV Testing as the Entry Point to HIV Prevention Sponsored by Gilead Sciences, Inc.


Plenary: Evolving HIV Testing as the Entry Point to HIV Prevention Sponsored by Gilead Sciences, Inc.


TBA March 30, 2021 5:00 pm - 6:00 pm

Bookmark and Share


Sponsored by Gilead Sciences, Inc.
Gilead HIV

This one-hour plenary session will focus on Evolving HIV Testing as the Entry Point to HIV Prevention.” Key topics to be explored include the current landscape of HIV testing, which includes the Ending the Epidemic plan and other initiatives, barriers, and gaps, as well as best practices highlighted through case studies. It will feature a presentation, a panel discussion, and an audience Q&A.

  • Describe opportunities to help strengthen the entry point to the care continuum through customizing HIV testing initiatives for priority populations 
  • Understand the importance of sustaining urgency for HIV testing, given the barriers/gaps and the impact of COVID-19 
  • Learn about current HIV testing initiatives at the federal, state, and local levels
  • Highlight best practices for HIV testing based on successful models from Washington, DC and the South

 

Moderator:

Marlene McNeese

Marlene McNeese
Assistant Director, Division of Disease Prevention and Control
Houston Health Department
Houston, TX

Panelists:

Clover Barnes

Clover Barnes, RN, BSN, MBA Bureau Chief, Integrated HIV Services Division
DC Department of Health
Washington, DC

Leandro Mena

Leandro Mena, MD, MPH
Professor of Infectious Diseases
Director, The University of Mississippi Medical Center, Center for HIV/AIDS Research, Education and Policy